Talent Risk

Talent Risk · Employers · Pharma & healthcare

Pharma & healthcare

12 pharma & healthcare employers rated by one rule, and 10 more in the news. 2 are cutting jobs, 5 show the signs; 2,341 job cuts announced in 90 days.

The board

CuttingSignsQuiet2.1% cut in 90 days, share of staff! unusual for them≈ cuts most quarters▲▼ moved in four weeksAI AI given as a reason

Every pharma & healthcare employer

Cutting first, then Signs, then Quiet; within each, the largest cuts for the employer’s size first. 10 more in the news but not rated can be included.

Label
AstraZenecaPharma & healthcare · UK▲ moved upUnusual for themCuttingConfirmed by the company or a formal notice (such as a US WARN notice)6260.7%12th Nov
Novo NordiskPharma & healthcare · Europe▲ moved upCuttingConfirmed by the company or a formal notice (such as a US WARN notice)3230.4%20th Nov
GSKPharma & healthcare · UKUnusual for themSignsReported, not yet confirmed: one major outlet1,2171.8%14th Oct
Johnson & JohnsonPharma & healthcare · USSignsConfirmed, but small: every notice under 100 jobs and under 0.1% of staff in 90 days1750.1%3rd Nov
BayerPharma & healthcare · EuropeSignsStepping down: cuts in the last 180 days, nothing new in 90——22nd Jul 2026
NovartisPharma & healthcare · EuropeSignsStepping down: cuts in the last 180 days, nothing new in 90——1st Jul 2026
PfizerPharma & healthcare · USSignsReported, not decided: said to be weighing cuts——4th Aug 2026
CVS HealthPharma & healthcare · USQuietNothing qualifying in the last 180 days———
PhilipsPharma & healthcare · EuropeQuietNothing qualifying in the last 180 days———
RochePharma & healthcare · EuropeQuietNothing qualifying in the last 180 days———
SanofiPharma & healthcare · EuropeQuietNothing qualifying in the last 180 days———
UnitedHealth GroupPharma & healthcare · USQuietNothing qualifying in the last 180 days———

Which jobs

Job functions named by pharma & healthcare employers in the last 12 months, counted by employer. 3 of 55 announcements say which jobs.

Named in job cuts

Building — filled in as reports are read.

    Named in hiring and redeployment

    Building — filled in as reports are read.

      Why they say they’re cutting

      The reasons pharma & healthcare employers and the reports give, counted by employer. Only reasons a source states.

      1. Restructuring or new strategy4Bayer, GSK, Novartis, Emergent BioSolutions
      2. Cutting costs3GSK, Novartis, Pfizer
      3. Closing sites or units2GSK, Novartis
      4. Moving work abroad1Novartis

      How: sites closing (3) · redeploying staff (1) · not replacing leavers (1)

      Employers giving each reason. 11 of 55 announcements state a reason; we count only what the sources say.

      What’s coming: rules that touch pharma & healthcare

      Official laws, rules, bills and consultations tagged to this sector and checked twice. Relevant through the sector, never a finding about any one employer.

      • UK · Proposed

        The Statement of Trade Union Rights Regulations 2026

        Impact assessment on regulations requiring employers to provide workers with written statements of trade union rights.

        Our reading Employers in all sectors could face costs from new duties to provide written statements about trade union rights to workers, which might affect hiring budgets or administrative staffing. The regulations could increase unionization rates if more workers access information about collective bargaining, potentially shifting pay negotiations and working conditions. Impact on job numbers, hours, or location is unlikely, though administrative roles handling worker communications could see changes.

        legislation.gov.uk · 12th November 2026

      • UK · New law

        The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 3) Regulations 2026

        Amendments to NHS pharmaceutical services regulations affecting provision and employment in English pharmacy services.

        Our reading These regulations amend how pharmaceutical services are provided through the NHS in England, but the text provided does not specify changes to workforce numbers, roles, pay, hours, automation, or work location that would affect jobs in pharmacies or related healthcare sectors.

        legislation.gov.uk · 11th November 2026

      • UK · Proposed

        Tax Reliefs Bill

        Bill on tax reliefs at 2nd reading; potential employment and hiring cost implications pending detailed provisions.

        Our reading Employers across all sectors could benefit from tax reliefs that might free up funds for hiring or investment. The bill's impact on employment levels and job creation is not yet clear from this stage of the legislative process.

        UK Parliament · 11th November 2026

      • UK · Open consultation

        Guided retirement: policy consultation

        Guided retirement implementation requirements for workplace and trust-based pension providers affecting employment transitions.

        Our reading Employers offering pension schemes could face new administrative requirements to guide workers toward retirement decisions, which might increase HR costs. The policy could affect how and when workers transition out of employment, potentially influencing hiring and retention patterns across all sectors. Implementation details for different employer types remain unclear pending consultation responses.

        GOV.UK · 3rd November 2026

      • US · Made or passedTakes effect 4th January 2027

        Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure

        Pharmacy benefit managers must disclose compensation details to health plan fiduciaries, affecting healthcare employer costs.

        Our reading Pharmacy benefit managers and affiliated brokers and consultants must disclose their compensation details to large self-insured employer health plans, which could affect how these service providers structure their fees and roles. This transparency requirement is unlikely to directly shift jobs between sectors, but could reduce demand for certain pharmacy benefit management roles if employers respond by renegotiating contracts or bringing services in-house. The rule applies to service providers working with large self-insured group health plans, not smaller employers or insurance carriers.

        Federal Register · 2nd November 2026

      Labels are our opinion, reached by applying one published rule to the sources listed on each employer’s page. How it works